EUPRAXIA PHARMACEUTICALS INC. Cash and Restricted Cash
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Cash and Restricted Cash of $80.56 million as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-13
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $80.56M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.10M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.34M.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.26M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $80.56M 40-F · filed 2026-03-13 |
| 2024-12-31 | $33.10M 40-F · filed 2026-03-13 |
| 2023-12-31 | $19.34M 40-F · filed 2026-03-13 |
| 2022-12-31 | $18.26M 40-F · filed 2025-03-20 |
| 2021-12-31 | $12.53M 40-F · filed 2024-04-01 |